Doseline Drugs Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 6 Year, 17 Days
- Last Filing with ROC 31 Mar 2020
About Doseline Drugs
Doseline Drugs Limited (DDL) is a Public Limited Indian Non-Government Company incorporated in India on 29 January 2019 (Six years 17 days old ). Its registered office is in Gorakhpur, Uttar Pradesh, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Digvijay Nath, Durgeshwar Solanki, and Indrajeet serve as directors at the Company.
Company Details
-
Location
Gorakhpur, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U74999UP2019PLC112945
-
Company No.
112945
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
29 Jan 2019
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Doseline Drugs?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Digvijay Nath
|
Director | 29-Jan-2019 | Current |
|
Durgeshwar Solanki
|
Director | 29-Jan-2019 | Current |
|
Indrajeet
|
Additional Director | 19-Sep-2020 | Current |
Financial Performance of Doseline Drugs.
Doseline Drugs Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Doseline Drugs?
Unlock access to Doseline Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Dcon India Nidhi LimitedDigvijay Nath, Durgeshwar Solanki and 1 more are mutual person
-
Meltos Chemical Private Limited
Digvijay Nath is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Doseline Drugs?
Unlock and access historical data on people associated with Doseline Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Doseline Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Doseline Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
